FDA Issues Warning Letter To Supplement Marketing Company ICL Health, LLC

ICL Health, LLC (“ICL”), a supplement marketing company in Tucson, Arizona recently received a warning letter from the U.S. Food and Drug Administration over claims relating to blood sugar management, stress relief, and immunity, to name a few.

The warning letter states that ICL claims that its products treat a number of conditions, including alcoholism, autoimmune diseases, fibromyalgia, depression, and rheumatoid arthritis. Some of the products cited in the warning letter include Good Sugar, Super Immune Space Sprinkles (targeting children), Cortisol Stress Reset and Nat-Stim.

Did you or someone you know purchase an ICL product based on representations that it may help treat certain conditions and feel you were ultimately misled by ICL’s advertising? If so, you may be a victim of false advertising. The attorneys at Finkelstein, Blankinship, Frei-Pearson & Garber, LLP have successfully represented consumers misled by deceptive claims and look forward to discussing this matter with you.